Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Novavax Inc
(NQ:
NVAX
)
174.84
USD
+16.74 (+10.59%)
Official Closing Price
Updated: 7:59 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Novavax Inc
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
How Worried Should Investors Be About the South African Coronavirus Variant?
Today 10:03 EST
Vaccine makers may have a solution.
Tags
MRNA
NVAX
PFE
From
Motley Fool
Is Short-Selling a Risk for Moderna?
Today 8:00 EST
Today, the risk is different for each vaccine stock.
Tags
VXRT
GME
Market News
From
Motley Fool
2 Green Flags for Pfizer in 2021 and 1 Yellow Flag
Today 6:47 EST
A clue: They have to do with revenue.
Tags
Market News
JNJ
MRNA
From
Motley Fool
Takeda Seeks Approval For Moderna's COVID-19 Shot In Japan
March 05, 2021
Takeda Pharmaceutical Co Ltd has asked regulators to approve the use of Moderna Inc’s COVID-19 vaccine (mRNA-1273 or TAK-919).
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
Blogs - TalkMarkets
WHO, SII Warn Of Raw Materials Shortage For COVID-19 Shots, Cites US Law As 'Serious' Limit:' Bloomberg
March 05, 2021
The head of Serum Institute of India (SII) and the World Health Organization’s chief scientist said that COVID-19 vaccine ...
Tags
News
GSK
MRK
From
Benzinga
Is BioNTech Stock a Buy?
March 05, 2021
The key ingredients are here for a multi-bagger over the next decade and beyond.
Tags
PFE
Market News
BNTX
From
Motley Fool
Why the FDA's Coronavirus Variant Guidance Is Great News for Pfizer, Moderna, and Johnson & Johnson
March 05, 2021
Testing vaccines against new variants will be much easier than it might otherwise have been.
Tags
Market News
JNJ
NVAX
From
Motley Fool
This Is the Cheapest Coronavirus Vaccine Stock Right Now
March 05, 2021
And let's take a look at the most overrated, the most promising, and the most under-the-radar coronavirus stocks too.
Tags
NVAX
PFE
OCGN
From
Motley Fool
Why New COVID Strains May Mean More Revenue for Pfizer and Moderna
March 05, 2021
Booster shots are on the horizon.
Tags
AZN
Market News
MRNA
From
Motley Fool
Takeda Seeks Approval For Moderna's COVID-19 Shot In Japan
March 05, 2021
Takeda Pharmaceutical Co Ltd(NYSE:TAK) has asked regulators to approve the use ofModerna ...
Tags
News
General
COVID/19 Vaccine
From
Benzinga
These 2 Companies May Be the Next to Enter the U.S. Vaccine Market
March 04, 2021
One is already selling vaccine elsewhere.
Tags
MRNA
PFE
AZN
From
Motley Fool
News From The Vaccine World
March 04, 2021
Less than a year before the COVID-19 started its relentless march across the globe Novavax (NASDAQ: NVAX) was facing delisting from the ...
Tags
Benzinga
PFE
MRNA
From
Benzinga
4 Stocks That Could Crash Soon
March 04, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>These companies used to be flying high, but fortunes can change quickly...
Tags
RIOT
TSLA
Market News
From
InvestorPlace
Novartis Lends Support To Manufacture CureVac's COVID-19 Shots
March 04, 2021
Swiss Pharma giantNovartis AG(NYSE:NVS)has agreed to helpCureVac BV(NASDAQ:CVAC) produce ...
Tags
COVID/19 Vaccine
Benzinga
PFE
From
Benzinga
Emergent BioSolutions Capable Of Manufacturing 1B COVID-19 Vaccine Doses Annually, CEO Says
March 04, 2021
Emergent BioSolutions Inc(NYSE:EBS) has built the capacity to produce vaccines fromAstraZeneca ...
Tags
MRNA
PFE
Benzinga
From
Benzinga
These 2 Elements in Novavax's Earnings Report Could Mean Billions for the Biotech
March 04, 2021
They're key as its coronavirus vaccine candidate approaches possible commercialization.
Tags
NVAX
PFE
BNTX
From
Motley Fool
Top Stocks To Invest In Now? 4 Biotech Stocks To Watch
March 03, 2021
Tags
Market News
From
StockMarket.com
Novavax Partners With Poland's Mabion For COVID-19 Vaccine Production: Bloomberg
March 03, 2021
Poland-based biotech firm Mabion has signed a preliminary agreement to manufactureNovavax Inc's(NASDAQ:NVAX) ...
Tags
Bloomberg
Market News
COVID/19 Vaccine
From
Benzinga
What Will the Stock Market Do Today? 3 Big Stories to Watch.
March 03, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>What will the stock market do today? It looks like investors will...
Tags
LYFT
AZN
GME
From
InvestorPlace
Jaguar Health Is on a Noble Mission But the Stock Needs a Nudge
March 03, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Jaguar Health is doing the right thing while JAGX stock is on the skids....
Tags
RKT
NASDAQ:JAGX,NASDAQ:NVAX,NYSE:RKT
Market News
From
InvestorPlace
OCGN Stock: Why Covid-19 Vaccine Play Ocugen Is Shooting Higher Today
March 03, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>OCGN stock is on the move today after vaccine partner Bharat Biotech...
Tags
OCGN
Today's Market
Market News
From
InvestorPlace
EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters
March 03, 2021
TheEuropean Commission is considering emergency approvalsfor COVID-19 vaccines as a faster alternative to lengthy ...
Tags
COVID/19 Vaccine
Reuters
Benzinga
From
Benzinga
Novavax's COVID Vaccine Trial: Are There Any Yellow Flags So Far?
March 03, 2021
Only details about the diversity of participants have been released at this point.
Tags
Market News
NVAX
From
Motley Fool
61 Biggest Movers From Yesterday
March 03, 2021
Gainers Rocket Companies, Inc. (NYSE: RKT) shares jumped 71.2% to close at $41.60 on Tuesday on continued strength after the ...
Tags
Markets
EYEN
RRD
From
Benzinga
Noteworthy Tuesday Option Activity: RH, NVAX, LULU
March 02, 2021
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in RH (RH), where a total of 2,594 contracts have traded so far, representing approximately...
Tags
Stocks
From
Market News Video
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 02, 2021
Gainers Novan (NASDAQ:NOVN) stock increased by 20.41% to $1.95 during Tuesday's regular session. The current volume ...
Tags
AVXL
NVAX
Markets
From
Benzinga
European Officials Seek To Garner Support For AstraZeneca COVID-19 Shot: CNBC
March 02, 2021
European officials areunder pressureto reverse restrictions on who can receive the Oxford-AstraZeneca ...
Tags
Health Care
NVAX
FDA
From
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
March 02, 2021
Gainers NanoViricides, Inc. (NYSE: NNVC) shares jumped 66% to $7.00. NanoViricides reported on the strong pan-coronavirus ...
Tags
TRXC
UWMC
FGEN
From
Benzinga
Why Novavax Stock Is Sinking Today
March 02, 2021
The company missed analyst estimates with its Q4 results and didn't have a firm date for filing for authorization of its COVID vaccine.
Tags
NVAX
Market News
From
Motley Fool
ROCE Insights For Novavax
March 02, 2021
Novavax (NASDAQ:NVAX) reported Q4 sales of $276.66 million. Earnings fell to a loss of $182.85 million, resulting in a 5.72% decrease ...
Tags
Market News
Benzinga
Earnings
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.